SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (348)2/10/1997 6:24:00 PM
From: Brad C. Dunlap   of 1762
 
Hi Bennett, believe it or not Idec currently has no active analyst coverage at this point in time. As mentioned earlier Eric Hecht of Morgan Stanley has left for Merrill Lynch and now Shekhar Basu has left Punk Ziegel for a yet to be disclosed but much larger brokerage firm. When the dust settles we should pick up coverage from both of the new firms where both analysts are now employed. Being that both Morgan and Punk Ziegel handled Idec's secondary offering and along with the strong fundamentals of Idec it should be interesting to see what kind of coverage developes from these firms as well as the 2 new companies that recently hired both analysts.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News